Stereotaxis Announces First GenesisX Robotic System Order
January 30, 2025 08:09 ET
|
Stereotaxis, Inc.
ST. LOUIS, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it has...
Stereotaxis Receives CE Mark Approval for the MAGiC Ablation Catheter
January 27, 2025 08:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it...
Oulu University Hospital Enhances Leadership in Arrhythmia Care with Advanced Genesis Robotic Technology
January 14, 2025 07:21 ET
|
Stereotaxis, Inc.
ST. LOUIS, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
Magbot Robotic Magnetic Navigation Ablation Catheter Approved by China’s NMPA
December 09, 2024 07:25 ET
|
Stereotaxis, Inc.
ST. LOUIS and SHANGHAI, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Shanghai MicroPort EP Medtech Co., Ltd. (688351.SH, “MicroPort EP”), today announced that the Magbot™ Magnetic...
Stereotaxis’ GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems
December 02, 2024 08:45 ET
|
Stereotaxis, Inc.
ST. LOUIS and SHENYANG, China, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Neusoft Medical Systems Co., Ltd (“Neusoft Medical Systems”) today announced that Stereotaxis’ latest...
Stereotaxis to Participate in Piper Sandler 36th Annual Healthcare Conference
November 26, 2024 08:28 ET
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David...
Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China
November 25, 2024 08:21 ET
|
Stereotaxis, Inc.
ST. LOUIS and SHANGHAI, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Shanghai MicroPort EP Medtech Co., Ltd. (688351.SH, “MicroPort EP”), today announced regulatory approval of the...
Hospital Da Luz is the First in Portugal to Adopt Genesis Robotic System
November 20, 2024 08:18 ET
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
Stereotaxis Reports 2024 Third Quarter Financial Results
November 11, 2024 16:02 ET
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
University of Kansas Medical Center Enhances Robotic Heart Care Program with Genesis Robotic Technology
November 06, 2024 08:25 ET
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...